ArticleScientific reports2024
An innovative approach to control fish-borne zoonotic metacercarial infections in aquaculture by utilizing nanoparticles.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Review
- Charting the Future: Advanced Technologies for Sustainable Parasite Control in Aquaculture.International journal of molecular sciences · 2025Review
- Molecular and pathological insights into gene expression and oxidative stress in Clinostomum complanatum and Euclinostomum heterostomum.Scientific reports · 2025Article
- Evaluation of Praziquantel effectiveness in treating Nile tilapia clinostomid infections and its relationships to fish health and water quality : By.BMC veterinary research · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fish-borne zoonotic trematodes (FBZTs) pose significant health risks and economic challenges worldwide. This study investigated the prevalence of encysted metacercariae (EMCs) in Nile tilapia (Oreochromis niloticus) from two Egyptian governorates and evaluated the antiparasitic efficacy of chitosan, silver, and selenium nanoparticles against these parasites. A cross-sectional analysis of 453 O. niloticus specimens revealed an overall EMC prevalence of 40.8%, with infection rates of 34.11% in Giza and 49.5% in Dakahlia. Clinostomid and Prohemistomid metacercariae were the most common, with mixed infections observed. Transmission electron microscopy characterized the synthesized nanoparticles, showing average diameters of 9.6-18.7 nm for chitosan, 13.2-19.8 nm for selenium, and 11.7-15.1 nm for silver nanoparticles. In vitro antiparasitic assays demonstrated varying efficacies among the nanoparticles. Against Clinostomum spp. metacercariae, chitosan nanoparticles showed the highest potency, achieving LC50 at 66 μg/ml after 30 min and LC90 at 100 μg/ml after 120 min. For Prohemistomum vivax EMCs, chitosan nanoparticles exhibited superior efficacy, achieving LC50 at 8 μg/ml after 1 h and LC90 at 16 μg/ml after 2 h. Silver and selenium nanoparticles showed lower efficacy for both parasite species. Scanning electron microscopy revealed significant ultrastructural damage to the parasite tegument following nanoparticle exposure, including disappearance of transverse ridges, integument shrinkage, and formation of blebs. This study provided valuable insights into the prevalence of FBZTs in Egyptian Nile tilapia and demonstrated the potential of nanoparticles, particularly chitosan, as effective antiparasitic agents. These findings pave the way for developing novel, targeted strategies to control fish-borne zoonotic trematodes, potentially reducing their impact on public health and aquaculture economies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.